Shionogi (Pharmaceutical Brands) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Shionogi (Pharmaceutical Brands) General Information

Description

Portfolio of four pharmaceutical brands. The portfolio includes four brand pharmaceutical products Triglide Tablets, Robinul and Robinul Forte Tablets, Furadantin Suspension and Fexmid Tablets.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Primary Office
  • 3-1-8 Doshomachi
  • Chuo-Ku
  • Osaka, 541-0045
  • Japan
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Shionogi (Pharmaceutical Brands) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Shionogi (Pharmaceutical Brands)‘s full profile, request access.

Request a free trial

Shionogi (Pharmaceutical Brands) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Shionogi (Pharmaceutical Brands)‘s full profile, request access.

Request a free trial